Cargando…
High-throughput quantification of ochronotic pigment formation in Escherichia coli to evaluate the potency of human 4-hydroxyphenylpyruvate dioxygenase inhibitors in multi-well format
4-hydroxyphenylpyruvate dioxygenase (HPD) is a key enzyme in the catabolism of tyrosine and therefore of great importance as a drug target to treat tyrosine-related inherited metabolic disorders (TIMD). Inhibition of this enzyme is therapeutically applied to prevent accumulation of toxic metabolites...
Autores principales: | Neuckermans, Jessie, Lequeue, Sien, Mertens, Alan, Branson, Steven, Schwaneberg, Ulrich, De Kock, Joery |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749435/ https://www.ncbi.nlm.nih.gov/pubmed/33365261 http://dx.doi.org/10.1016/j.mex.2020.101181 |
Ejemplares similares
-
A robust bacterial assay for high-throughput screening of human 4-hydroxyphenylpyruvate dioxygenase inhibitors
por: Neuckermans, Jessie, et al.
Publicado: (2019) -
A robust bacterial high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of alkaptonuria
por: Lequeue, Sien, et al.
Publicado: (2022) -
A novel enzymatic assay for the identification of 4-hydroxyphenylpyruvate dioxygenase modulators
por: Parkins, Andrew, et al.
Publicado: (2023) -
Computer-Aided and AILDE Approaches to Design Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors
por: Shi, Juan, et al.
Publicado: (2022) -
Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells
por: De Kock, Joery, et al.
Publicado: (2020)